Abstract
Amgen and Novartis are developing erenumab (AIMOVIG (TM), erenumab-aooe)-a fully human monoclonal antibody calcitonin gene-related peptide (CGRP) rece......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
